|
Indication & Dosage |
|
|
Oral |
HYPERTHYROIDISM |
Adult:
Initially, 20-60 mg daily as a single or divided dose, reduced gradually once euthyroidism is achieved. Maintenance: 5-15 mg daily for at least 1 yr or 18 mth. |
|
Oral |
HYPERTHYROIDISM |
Child:
4-12 yr: Initially, 15 mg daily. |
|
Oral |
GRAVE'S DISEASE |
Adult:
Initially, 20-60 mg daily as a single or divided dose, reduced gradually once euthyroidism is achieved. Maintenance: 5-15 mg daily for at least 1 yr or 18 mth. |
|
Oral |
GRAVE'S DISEASE |
Child:
4-12 yr: Initially, 15 mg daily |
|
Oral |
PREPARATION FOR THYROIDECTOMY |
Adult:
Initially, 20-60 mg daily as a single or divided dose, reduced gradually once euthyroidism is achieved. Maintenance: 5-15 mg daily for at least 1 yr or 18 mth. |
|
Oral |
PREPARATION FOR THYROIDECTOMY |
Child:
4-12 yr: Initially, 15 mg daily. |
|
Oral |
ADJUNCT TO RADIO-IODINE THERAPY |
Adult:
Initially, 20-60 mg daily as a single or divided dose, reduced gradually once euthyroidism is achieved. Maintenance: 5-15 mg daily for at least 1 yr or 18 mth. |
|
Oral |
ADJUNCT TO RADIO-IODINE THERAPY |
Child:
4-12 yr: Initially, 15 mg daily |
|
|
|
Administration |
May be taken with or without food. (Take consistently w/ or without meals.) |
|
|
Precautions |
Liver diseases, pregnancy, lactation. |
|
|
Potentially Life-threatening
Adverse Drug Reactions |
Mild leucopaenia, sore throat, mouth ulcers, fever, bruising, malaise; rarely cholestatic jaundice; nephrotic syndrome. Nausea, loss of taste, headache, arthralgia, alopoecia. |
|
|
Adverse Drug Reactions |
Agranulocytosis, aplastic anaemia, hypoprothrombinaemia, neutropaenia; hypothyroidism and goitre. |
|
|
Interactions |
Increased sensitivity to warfarin in hyperthyroidism and careful control required as patient is rendered euthyroid. |
|
|
|
|